Abeona Therapeutics Inc (NAS:ABEO)
$ 4.2 -0.25 (-5.62%) Market Cap: 171.56 Mil Enterprise Value: 124.74 Mil PE Ratio: 0 PB Ratio: 7.51 GF Score: 45/100

Q2 2020 Abeona Therapeutics Inc Earnings Call Transcript

Aug 11, 2020 / 12:30PM GMT
Release Date Price: $72.75 (-2.68%)
Operator

Good day and welcome to Abeona Therapeutics Second Quarter 2020 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded. I'll now introduce your host for today's conference, Greg Gin, Vice President of Investor Relations at Abeona. Please go ahead.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR

Thanks, Christie. I'd like to welcome everyone, and thank you for joining us on Abeona Therapeutics conference call to discuss our second quarter 2020 financial results and business update. Yesterday after the close of U.S. financial markets, Abeona issued a press release, which is posted on our website at www.abeonatherapeutics.com.

On the call today with prepared remarks are João Siffert, Chief Executive Officer of Abeona; and Ed Carr, Chief Accounting Officer. We are also joined by Michael Amoroso, Chief Commercial Officer.

After prepared remarks, we will host the Q&A session. Before we start, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot